| Page Range | 22527-22528 | |
| FR Document | 2015-09298 |
[Federal Register Volume 80, Number 77 (Wednesday, April 22, 2015)] [Notices] [Pages 22527-22528] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-09298] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. FDA-2014-M-1452, FDA-2014-M-1596, FDA-2014-M-1597, FDA- 2014-M-1599, FDA-2014-M-1735, FDA-2014-M-1736, FDA-2014-M-2042, FDA- 2014-M-2246, FDA-2014-M-2248, and FDA-2014-M-2376] Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications AGENCY: Food and Drug Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA) is publishing a list of premarket approval applications (PMAs) that have been approved. This list is intended to inform the public of the availability of safety and effectiveness summaries of approved PMAs through the Internet and the Agency's Division of Dockets Management. ADDRESSES: Submit written requests for copies of summaries of safety and effectiveness data to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. Please cite the appropriate docket number as listed in table 1 when submitting a written request. See the SUPPLEMENTARY INFORMATION section for electronic access to the summaries of safety and effectiveness. FOR FURTHER INFORMATION CONTACT: Nicole Wolanski, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 1650, Silver Spring, MD 20993-0002, 301- 796-6570. SUPPLEMENTARY INFORMATION: I. Background In accordance with sections 515(d)(4) and (e)(2) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 360e(d)(4) and (e)(2)), notification of an order approving, denying, or withdrawing approval of a PMA will continue to include a notice of opportunity to request review of the order under section 515(g) of the FD&C Act. The 30-day period for requesting reconsideration of an FDA action under Sec. 10.33(b) (21 CFR 10.33(b)) for notices announcing approval of a PMA begins on the day the notice is placed on the Internet. Section 10.33(b) provides that FDA may, for good cause, extend this 30-day period. Reconsideration of a denial or withdrawal of approval of a PMA may be sought only by the applicant; in these cases, the 30-day period will begin when the applicant is notified by FDA in writing of its decision. The regulations provide that FDA publish a quarterly list of available safety and effectiveness summaries of PMA approvals and denials that were announced during that quarter. The following is a list of approved PMAs for which summaries of safety and effectiveness were placed on the Internet from October 1, 2014, through December 31, 2014. There were no denial actions during this period. The list provides the manufacturer's name, the product's generic name or the trade name, and the approval date. Table 1--List of Safety and Effectiveness Summaries for Approved PMAs Made Available From October 1, 2014, Through December 31, 2014 ---------------------------------------------------------------------------------------------------------------- PMA No., Docket No. Applicant Trade name Approval date ---------------------------------------------------------------------------------------------------------------- P040037/S060, FDA-2014-M-1452........ W.L. Gore & Associates, GORE VIABAHN September 19, 2014. Inc. Endoprosthesis, GORE VIABAHN Endoprosthesis with Heparin. P070015/S122, FDA-2014-M-1596........ Abbott Vascular, Inc... XIENCE V[supreg] and October 3, 2014. XIENCE nano[supreg] Everolimus Eluting Coronary Stent System. P110019/S066, FDA-2014-M-1596........ Abbott Vascular, Inc... XIENCE PRIME[supreg] October 3, 2014. and XIENCE PRIME LL Everlimus Eluting Coronary Stent System. P130024, FDA-2014-M-1597............. Lutonix, Inc........... Lutonix 035 Drug Coated October 9, 2014. Balloon PTA Catheter. P110023/S007, FDA-2014-M-1599........ ev3, Inc............... EverFlexTM Self- October 10, 2014. Expanding Peripheral Stent System. P120005/S018, FDA-2014-M-1735........ Dexcom, Inc............ Dexcom G4TM PLATINUM October 21, 2014. Continuous Glucose Monitoring System. P130026, FDA-2014-M-1736............. St. Jude Medical....... TactiCath October 24, 2014. Quartz[supreg] Catheter and TactiSysQuartz[supreg] Equipment. P120011, FDA-2014-M-2042............. Ideal Implant, Inc..... IDEAL IMPLANT[supreg] November 14, 2014. Saline-filled Breast Implant. P130007, FDA-2014-M-2246............. Animas Corp............ Animas Vibe System..... November 25, 2014. P140020, FDA-2014-M-2248............. Myriad Genetic BRACAnalysis CDxTM..... December 19, 2014. Laboratories, Inc. P020012/S009, FDA-2014-M-2376........ Suneva Medical, Inc.... Bellafill.............. December 23, 2014. ---------------------------------------------------------------------------------------------------------------- [[Page 22528]] II. Electronic Access Persons with access to the Internet may obtain the documents at http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/PMAApprovals/default.htm. Dated: April 16, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015-09298 Filed 4-21-15; 8:45 am] BILLING CODE 4164-01-P
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Contact | Nicole Wolanski, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 1650, Silver Spring, MD 20993-0002, 301- 796-6570. | |
| FR Citation | 80 FR 22527 |